The FDA approved therapies to treat pain, type 2 diabetes, hormone deficiency, and juvenile idiopathic arthritis in September 2020.
A longitudinal care model for diabetes management that puts registered nurses in charge of overseeing a proactive and personalized intervention for diabetes patients resulted in enhanced care.
Intrauterine exposure to maternal gestational diabetes is associated with an increased cardiovascular disease risk and risk factors in offspring up to age 35 years.
Researchers developed a quality improvement project protocol to describe ways to support diabetes management in psychiatric inpatient settings.
The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.
Researchers sought to determine whether triglyceride levels were independently associated with cardiovascular disease among patients with coronary artery disease and type 2 diabetes.
Children who received a new diagnosis of type 1 diabetes during the COVID-19 pandemic are presenting with higher rates of diabetic ketoacidosis than in the previous 2 years.
This study found that diabetic patients with COVID-19 had lower lymphocyte counts and longer hospital stays.
Researchers used electronic health records to further understand the clinical features and gaps in treatment approaches for patients with severe hypercholesterolemia.
Many children are eligible for type 2 diabetes screening, but few test positive for prediabetes or diabetes.
The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea.
In individuals with prediabetes, 12 weeks of cinnamon supplementation improved fasting plasma glucose and glucose tolerance.
Two clinicians share their thoughts on best practices in navigating pandemic-related care for older adults with diabetes.
The analysis included 241,551 patients monitored for a median of 4 years.
Several companies have initiated recalls of metformin extended-release tablets due to the possibility of unacceptable levels of N-Nitrosodimethylamine, a probable human carcinogen.
For COVID-19 patients without a previous diagnosis of diabetes, fasting blood glucose (FBG) ≥7.0 mmol/L is an independent predictor of 28-day mortality.
The prevalence of metabolic syndrome is rising at an unequal rate among different patient demographics.
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.
A consensus statement outlines the benefits and barriers associated with diabetes self-management education and support (DSMES) in adults with type 2 diabetes.
Metabolic traits associated with adult diabetes risk may be detectable by age 8 years